EMA: Should The Comparative Efficacy Requirement Be Waived For Biosimilars?

 
• By Ian Schofield
  
Clinical Trial New Vaccine Testing Medicine Drug 3d Illustration
Regulators are considering dropping comparative efficacy trial requirements for biosimilars • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography